Market
Cantor Fitzgerald slashes price target on RAPT Therapeutics Inc [RAPT] – find out why.
RAPT Therapeutics Inc [NASDAQ: RAPT] slipped around -19.1 points on Tuesday, while shares priced at $6.87 at the close of the session, down -73.55%. The company report on February 20, 2024 at 7:30 AM that RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon. –
